PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
Clinical trial NCT06335147 · UNKNOWN
Trial details
- NCT number
- NCT06335147
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2026-01-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.